ANTISENSE MODULATION OF SRCC EXPRESSION

Details for Australian Patent Application No. 2002318139 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors BENNETT, Frank, C.; WATT, Andrew, T.

Pub. Number AU-A-2002318139

PCT Number PCT/US02/15684

PCT Pub. Number WO2002/095053

Priority 09/860,473 18.05.01 US

Filing date 16 May 2002

Wipo publication date 3 December 2002

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 09/860,473 18.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002318139

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318140-NOVEL ANTIGEN BINDING MOLECULES FOR THERAPEUTIC, DIAGNOSTIC, PROPHYLACTIC, ENZYMATIC, INDUSTRIAL, AND AGRICULTURAL APPLICATIONS, AND METHODS FOR GENERATING AND SCREENING THEREOF

2002318138-METHODS OF TREATING ANTIBODY-MEDIATED PATHOLOGIES USING AGENTS WHICH INHIBIT CD21